Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Overweight

• The Effects of Remimazolam on the Incidence of Severe Hypoxia During Sedated Hysteroscopy for Assisted Reproduction in Overweight or Obese Patients
• A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
• Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity
• Semaglutide for Post-Smoking Cessation Weight Management
• A Trial to Learn How Safe AZD9550 is in People With Type 2 Diabetes Who Are Overweight or Obese
• A First-In-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB014295
• A Chronic Weight Management Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
• A Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese Participants
• A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or Obese
• A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo
• Dexamethasone/Pancreatic Clamp P&F
• A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight
• A Study of HS-20094 Evaluating Weight Loss in Obese and Overweight Chinese Subjects
• Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes
• A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
• A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
• A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight
• A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
• A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin
• A Study of CT-868 in Type 1 Diabetes Mellitus
• Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects
• A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
• A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range
• A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
• Effect of Transcranial Direct Current Stimulation (tDCS) and Probiotic Supplementation in Overweight Adults
• A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
• A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers
• A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease
• A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
• A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee
• A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
• A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 in Healthy Overweight/Obese Volunteers
• A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood
• Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)
• A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes
• Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes
• A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
• A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
• A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants
• A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities
• A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects
• Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus
• A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight
• A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
• A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants
• Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults
• The Effect of Colchicine on Food-related Effort-based Decision Making in Brain and Behaviour in Overweight and Obesity
• Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus
• Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression
• Randomized, Double-blind, Placebo-controlled Phase 1b Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects
• A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM
• A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906
• Safety and Efficacy of Sodium Pentaborate Pentahydrate in People With Overweight and Obesity
• A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese
• Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Participants With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus
• Effect of Probiotics Among Overweight and Obese Saudi Adults
• A Study of LY3305677 in Participants With Obesity Or Overweight
• Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese
• A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants
• A Study of IBI362 in Participants With Obesity or Overweight
• A Study of LY3457263 in Obese Participants
• Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range
• A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
• A Study of LY3437943 in Chinese Participants With Obesity Or Overweight
• A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
• Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol In Overweight Or Obesity Patients
• Assess the Safety, Tolerability, and Pharmacokinetics of AZD6234 Following Single Ascending Dose Administration to Healthy Subjects Who Are Overweight or Obese
• Orlistat Reduces Uric Acid in Overweight/Obese Patients With Hyperuricemia
• A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight
• Efficacy of Oral Semaglutide in Overweight or Obesity
• Use of Empagliflozin to Treat Prediabetes
• Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM
• A Research Study to See How Well CagriSema Helps People Losing Weight in People Who Have a Body Weight Above the Healthy Range and Type 2 Diabetes
• A Study of LY3541105 in Healthy and Overweight Participants
• A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity
• Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia
• Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma
• A Study of LY3502970 in Healthy Overweight and Obese Participants
• A Study of TG103 Injection in Overweight or Obesity
• A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906
• A Study of LY3841136 in Healthy and Overweight Participants
• Efficacy and Safety of ALT-801 in the Treatment of Obesity
• Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)
• A Research Study of How NNC0174-0833 Behaves in Chinese Volunteers Who Are Normal Weight, Overweight or With Obesity
• Pharmacokinetics of Benaglutide Injection in Overweight/Obese Adults
• A Study of VI-0521 on Ambulatory Blood Pressure in Overweight or Obese Subjects
• A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight
• Semaglutide to Reduce Atrial Fibrillation Burden
• A Study to Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients
• ALT-801 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus (T2DM)
• Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity
• A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
• A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial Participants
• Latino Semaglutide Study
• A Study to Test How Well Overweight Men Tolerate Different Doses of BI 3006337
• A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes
• Assessment of the Safety, Tolerability, and Pharmacokinetic of GMA106
• A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
• Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)
• A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)
• ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)
• The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.
• Effects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyperandrogenemia.
• A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or Obesity
• Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer
• A Study of IBI362 in Participants With Obesity or Overweight for Weight Loss
• A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide
• Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patients
• A Study of LY3437943 in Participants Who Have Obesity or Are Overweight
• First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes
• Effects of Capsimax on Appetite, Energy Intake and Blood Pressure
• Effect of Quinine Hydrochloride in Overweight Population on Food Intake, Hunger and Gut Peptide Release
• ALY688-SR in Generally Healthy Overweight or Obese Adults
• A Study of TG103 Injection in Overweight/Obese Subjects Without Diabetes
• A Drug-Drug Interaction Study Between PF-06882961 and PF-06865571 in Healthy Adult Participants and Overweight Adults or Adults With Obesity Who Are Otherwise Healthy
• A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus
• A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD
• Effect of Akkermansia Muciniphila WST01 Strain in Overweight or Obese Patients With Type 2 Diabetes
• Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?
• Clinical Study of IBI362 in Healthy Chinese Male Subjects
• Sumatriptan and Glucose
• Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects
• A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight
• Xla1 Christensenella Minuta, Phase I, Randomized, Partially Placebo-controlled Double-blind Protocol, Evaluating Safety, Tolerability and Impact on the Gut Microbiota in Healthy Volunteers, Overweight and Obese Adults
• A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss
• A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight
• STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITY
• Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity
• Targeting the Gut-brain Axis to Facilitate Weight Loss in High Fat Diet Consumers
• The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients
• Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)
• Pharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b)
• Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)
• ALT-801 in Healthy Overweight and Obese Volunteers to Study Safety and Tolerability
• Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbidities
• A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary)
• First-in-human Study to Assess Safety and Tolerability of a Single Subcutaneous Dose of SAR441255 in Lean to Overweight Subjects
• Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity
• Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study
• Relative Levels of BMS-986036 in Blood Plasma in Healthy, Overweight, and Obese Participants Following Subcutaneous Administration Via Auto-injector Versus Pre-filled Syringe
• Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities
• A Study to Test How Well Different Doses of BI 1356225 Are Tolerated by Men and Women With Obesity or Overweight
• Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI362 in Overweight or Obesity Subjects
• A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide
• GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
• Metformin in Dengue With Obesity
• Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate Obese and Overweight Subjects
• A Study of Tirzepatide in Overweight and Very Overweight Participants
• Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants With Type 2 Diabetes
• Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
• First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes
• Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOS
• Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity
• A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens
• A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of Semaglutide
• A Research Study Looking Into Blood Levels of NNC0174-0833 in People With Normal and Impaired Kidney Function
• Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc
• A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
• A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
• Study for Multiple Doses of HM15136 in Obese or Overweight Subjects With Comorbidities
• A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
• A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects
• A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity
• Research Study to Investigate the Effect of NNC0174-0833 on a Birth Control Pill in Women Who Are Not Able to Become Pregnant
• Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity
• Research Study to Investigate How a Study Medicine (NNC9204- 1177) Affects Blood Levels of Other Medicines in Healthy People
• Effect and Safety of TCM-FMD in Phlegm-Dampness Type Overweight/Obesity Patients(EASTAR)
• Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients
• A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
• A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity
• A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
• Effect of Bitter in Overweight Female Volunteers
• A Study of FT 4101 in Overweight/Obese Participants With NASH
• Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.
• Homeopathy for Overweight and Obesity in Mexican Adolescents
• A Phase IV Safety and Efficacy of VI-0521 in Obese Adolescents
• Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
• Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.
• A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity
• ENAC Blockade and Arterial Stiffness
• STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity
• A Research Study of How NNC0174-0833 Behaves in Japanese and Caucasian Volunteers Who Are Normal Weight, Overweight or With Obesity
• A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of PHP-303 in Otherwise Healthy Overweight or Obese Subjects
• A Study to Evaluate the Safety and Tolerability of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
• Aspirin for Prevention of Preeclampsia in Healthy, Nulliparous Obese and Overweight Pregnant Women
• Lorcaserin and Behavioral Modification for Overweight and Obesity Management in Chinese Obese Patients
• A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obese
• Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
• Orlistat/Phentermine Versus Placebo/Phentermine
• Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity
• Brain Dopamine Function in Human Obesity
• Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program
• A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese
• A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes Mellitus
• A Study of JNJ-64565111 After Single Subcutaneous Administration at Different Injection Sites in Otherwise Healthy Overweight/Obese Adult Participants and a Study of JNJ-6456511 in Otherwise Healthy Obese Adult Participants After Multiple Dose
• Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
• A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese
• BEFORE Study, Efficacy of Refigura
• A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
• Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity
• Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
• STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
• Inflammatory Axis and Sirtuins' in Overweight Pre-diabetics Patients
• A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity
• Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Participants With Type 2 Diabetes
• A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period
• Effect of Vitamin D Supplement in Induction of Ovulation in Overweight Women With Polycystic Ovary Syndrome
• A Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Overweight/Obese Subjects of Japanese or Chinese Descent
• Predictors of Lorcaserin-Induced Weight Loss
• Research of Exenatide for Overweight/Obese PCOS Patients With IGR
• A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patients
• Walnuts to Achieve Lasting NUTrition to Prevent Diabetes
• Vitamin D3 Treatment and Homocysteine Concentrations Among Overweight Reproductive Women
• Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity
• Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes
• A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
• A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes
• A Study To Assess The Safety, Tolerability, And Pharmacokinetics (PK) Of Multiple Doses Of PF-06865571 In Healthy, Including Overweight And Obese, Adult Subjects
• Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins
• Intraperitoneal Local Anesthetic in Bariatric Surgery Study (iLABS Study)
• Evaluation of Safety, Efficacy and Thermogenesis-induction of RZL-012 in Overweight and Obese Volunteers
• Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
• Study of Pharmacodynamics of LIK066 in Overweight and Obese Women With Polycystic Ovary Syndrome
• The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS
• A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults
• Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity
• Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
• Fixed Dose Combination of Fluoxetin and Metformin in the Management of Overweight and Obesity
• A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese
• First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity
• Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes
• Evaluation of PK and Biomarkers After UDCA Administrations to Subjects Who Are Overweight and Have Liver Problems
• Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin
• The Addition of Probiotic Consumption to a Nutritional Intervention and Caloric Restriction on Body Weight and Composition in Overweight Participants
• Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight
• A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.
• Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat
• Impact of Metformin on In Vitro Fertilization Outcomes in Overweight and Obese PCOS Women
• Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus
• Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity
• A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy Subjects
• A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity
• Capsaicin Effect on Cytokines Profile in Dyslipidemia
• Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes
• MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
• International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan
• Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ Body Surface Area (BSA) > 2.0
• Metformin Induces a Dietary Restriction-like State in Human
• Liraglutide for HIV-associated Neurocognitive Disorder
• A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.
• Effect of Tulsi (Ocimum Sanctum) on Biochemical Parameters in Young Overweight and Obese Subjects
• Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes
• Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients
• Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BFKB8488A in Otherwise Healthy Overweight and Obese Participants With Likely Insulin Resistance
• A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects
• Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized Approach
• A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
• RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity
• The Effect of Gelesis100 on the Pharmacokinetics of Metformin
• Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs
• Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes
• Study to Assess the Relative Potency of Multiple Oral Doses of LUM001 and SHP626 in Overweight and Obese Adults as Assessed by Fecal Bile Acid Excretion
• To Evaluate the Safety, Tolerability, PK, PK-PD Relation of KD101 in the Fed State in Obese or Overweight Subjects
• Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RM-493 Administered to Healthy, Obese, Non-diabetic Volunteers
• Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients
• Mechanisms of Weight Loss With SGLT2 Inhibition
• A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.
• Dapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women
• The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS)
• Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male Subjects
• Safety and Tolerability Study of SHP626 in Overweight and Obese Adults
• Oxytocin Effects on Food Motivation Pathways
• Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
• Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects
• Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects
• Effects of Onion Peel Extract on Endothelial Function
• Liver and Fat Regulation in Overweight Adolescent Girls
• Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management
• GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients
• An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury
• Phase 1b/2a Study to Evaluate Safety and Efficacy of RM-493 in Obese Patients
• A Study to Evaluate AZP531 in Healthy Volunteers, Overweight/Obese Volunteers and Patients With Type 2 Diabetes Mellitus
• The Efficacy of Bariatric Surgery Compared to Medical Therapy in Controlling Type2 Diabetes Mellitus in Patients With Non Morbid Obesity.
• Routine Irrigation With Ropivacaine vs. Lidocaine vs. Saline of Surgical Bed in Sleeve Gastrectomy
• Vitamin D Supplementation for the Prevention of Cardiovascular Risk
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Mul
• Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
• A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight
• Obex, a Nutritional Supplement, in Overweight and Obese Spanish Women
• Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects
• Metformin Therapy for Overweight Adolescents With Type 1 Diabetes
• Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187
• Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese Individuals
• Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
• An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi Syndrome
• Multiple Dose Safety Tolerability, Pharmacokinetics And Midazolam Interaction In Healthy Overweight And Obese Subjects
• Oxidized Omega-3 Supplements With Different Oxidation
• Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer
• Zonisamide for the Treatment of Obstructive Sleep Apnea in Overweight/Obese Patients
• Clinical Trial to Study the Safety Tolerability, Pharmacokinetics, Food Effect & Pharmacodynamics of a New Compound P7435 in Healthy, Overweight and/or Obese Subjects
• Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects
• Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects
• Liraglutide In Overweight Patients With Type 1 Diabetes
• Phase 2 Study to Evaluate Safety and Efficacy of Rm-493 in Obese Patients
• Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism
• Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese
• The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects
• A Study To Test The Safety, Amount And Effects Of PF-06282999 In Healthy Overweight Adults And A Study To Test The Effects Of PF-06282999 On The Amount Of The Approved Drug, Midazolam, In Healthy Adults
• Angiotensin II Blockade and Inflammation in Obesity
• Effect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II)
• A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002)
• Liraglutide in Type 1 Diabetes
• Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients
• Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
• Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic Patients
• A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms
• A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects
• Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This Setting
• Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Body Mass Index ≥ 27
• Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
• A Study Of PF-04620110 As A Modified-Release Formulation In Healthy Overweight Or Obese Subjects
• Effect of Calcium + Vitamin D Supplementation on Weight Management in Very-low Calcium Consumers
• Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
• Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess
• Effect of Metformin on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess
• Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
• Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
• Mifepristone Effects on Glucose Intolerance in Obese/Overweight Adults
• Orlistat Induced Modulation on the Fatty Acid Composition in Obese Females
• Survey on the Pharmacy Follow-up of Alli Purchasers
• The Effect of Montelukast on Asthma Control in Overweight/Obese Atopic Asthmatics
• Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function
• Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After Treatment With Basal Insulin
• Diacerein on Insulin Secretion in Diabetes
• Metformin Versus Acarbose Treatment in Infertile Overweight Women With Polycystic Ovary Syndrome (PCOS)
• Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
• Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes
• Internet-Administered Smoking Cessation Treatment for Overweight and Obese Smokers
• To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Administration of AZD8329
• Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
• Study of the Effect of Moxonidine and Diet on Sympathetic Functions in Young Adults With Obesity
• Safety & Tolerability of a Combination of Antidepressant and Peptic Ulcer Drug in Overweight Healthy Subjects
• A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects
• Xinju Xiaogao Prescription Study on Overweight
• AZD7687 Multiple Ascending Dose Study
• Effects of Pioglitazone on Insulin Sensitivity in Healthy Overweight and Obese Males (MK-0000-170)
• Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers
• Pharmacokinetics in Morbid Obesity After Bariatric Surgery
• A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers
• A Study of the Safety of R256918 in Obese Patients
• A Multiple Dose Study Of Ertugliflozin (PF-04971729, MK-8835) In Otherwise Healthy Overweight And Obese Volunteers (MK-8835-037)
• Armodafinil in Binge Eating Disorder (BED)
• A Weight Loss Study in Overweight Men and Women
• WS®1442 in Slightly Overweight Subjects
• A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers
• Homeopathic Medication and Nutritional Oriented Diet to Treat Overweight Pregnant Women With Mental Disorder
• Metformin in Overweight Type 2 Diabetes Mellitus
• A Functional Magnetic Resonance Imaging (fMRI) Study in Overweight and Obese Men (0000-103)
• Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects
• Nutritional Problems After Lung and Heart Transplantation
• Effect of Fenofibrate on Sleep Apnea Syndrome
• An Ascending Multi-Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers
• A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.
• A Single Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers
• Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin Treatment
• Study to Examine Safety, Tolerability and Effect on Body Weight of Subcutaneous AC2307 in Obese or Overweight Subjects
• Effect of Orlistat in Body Composition
• Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/Obese Volunteers
• A Study Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Naltrexone SR/ Bupropion SR Therapy in Overweight or Obese Subjects
• Trial of Leptin Administration After Roux-en-Y Gastric Bypass
• Long-Term Effect of 10 mg Versus 20 mg Rimonabant in Overweight or Obese Patients
• Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects
• Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female Volunteers
• A Study of the Safety and Effectiveness of Canagliflozin (JNJ-28431754) in Promoting Weight Loss in Overweight and Obese Patients Who do Not Have Diabetes
• Efficacy and Safety Trial to Evaluate the Effect of SCH 497079 on Weight in Obese and Overweight Participants (Study P05483)(COMPLETED)
• A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus
• Targeting Inflammation Using Salsalate in CardioVascular Disease
• A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression
• A Study of the Safety and Effectiveness of JNJ-16269110 (R256918) in Overweight and Obese Patients
• BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus
• Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating Disorder
• A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects
• A Study of Naltrexone SR/ Bupropion SR in Overweight and Obese Subjects Who Are Nicotine-Dependent
• REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents
• BMS-646256 in Obese and Overweight Type 2 Diabetics
• A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects
• Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes
• Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects
• A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes
• Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS
• Effects of Betahistine Hydrochloride in Overweight Women
• A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program
• Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)
• Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)
• Safety & Efficacy of Omega-3 Fish Oil in Overweight Children & Adolescents
• Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects
• A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects
• A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects
• BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management
• A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects
• A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients
• Calcium Supplementation for a Healthy Weight-Lite (CaSHeW Lite)
• An Investigational Drug Study to Assess Weight Loss in Obese and Overweight Patients (0364-037)(TERMINATED)
• Effect of Calcium/Vitamin D Supplementation on Body Weight and Fat Loss.
• Exenatide and Metformin Therapy in Overweight Women With PCOS
• Safety, Toleration and Pharmacokinetics of Single Intravenous Doses of Peptide YY in Overweight Adults
• Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity
• Optimizing Body Composition for Function in Older Adults
• Ability of a Tea Leaf Extracts Preparation to Slow Down Carbohydrate and Fat Absorption
• A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes
• A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.
• A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients
• The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia
• Effect of Reduction of Inflammatory Status on Glucose Metabolism in Overweight Men
• Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension
• A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin
• VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women
• Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)
• The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects
• The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus
• Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder
• Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder
• Supplemental Calcium in Overweight People